Trinity Life Sciences news and milestones

Trinity Capital (TRIN) priced an underwritten public offering of $350 million of 7.50% unsecured not

Author Faith DeFreitas Director, Advanced Analytics For years, the life sciences industry has invested heavily in finding patients earlier, more accurately, and at greater scale.…

News, Reviews, Release Date, Trailers, Gameplay and more for Trinity Trigger DX

Locked Out or Leveled Up? Authors Wenting Zhang Director, Value, Access, and Pricing Rya Zhang Senior Consultant, Value, Access, and Pricing Venus Leung Associate Consultant Navt…

Mike Falvo Executive Director, Management Advisor CI & AA PMR's Trusted Role and Emerging Gap: An Introduction Primary market research (PMR) has long been a trusted advisor to br…

Authors Karthik Badri Partner, Commercial Strategy Nathan George Principal, Commercial Strategy Oncology markets are no longer defined only by tumor type or line of therapy. AI,…

Authors Jessica Counihan Associate Principal Nayli Ma Senior Consultant Additional Contributors: Mary Fletcher-Louis and Alex Chiang Direct-to-patient (DTP) channels have quietly…

A new study led by Duke scientist Richard F. Kay overturns a long-held idea about how primates, including humans, came to have such large, sophisticated brains.

Scott Evangelista Chief Executive Officer When I sat down with Jane King on New to the Street, I had one message I wanted every viewer to walk away with. Trinity is the leader in…

Over 7T AI debt by 2029, There can be no Neoclouds without the Trinity. Nvidia's Backstop Economics Explained. AI Debt Needs Quantified. Nvidia's Objective is to Broaden Compute…

Mike Falvo Executive Director, Management Advisor CI & AA Pharmaceutical competitive intelligence (CI) has quietly become one of pharma's most strained functions. The TGaS Compet…

Forgotten photos of the Trinity detonation show the immensity of the project

How proper environment setup turns AI coding assistants from novelty into genuine infrastructure. Nix makes everything reproducible. SSH makes everything reachable. Claude ties i…

Abstract page for arXiv paper 2602.17004: Arcee Trinity Large Technical Report

Most open source models that claim agentic capability are really just instruction-tuned models with tool calling bolted on. They can call a function. They cannot think across ten…

In an industry defined by uncertainty, few leaders have built their careers as deliberately around navigating complexity as Scott Evangelista. As CEO of Trinity Life Sciences, a…

We're on a journey to advance and democratize artificial intelligence through open source and open science.

Trinity-Large-Thinking is live. A frontier open reasoning model for complex, long-horizon agents and multi-turn tool calling released under Apache 2.0.

Trinity Large Thinking is a powerful open source reasoning model from the team at Arcee AI. $0.25 per million input tokens, $0.80 per million output tokens. 262,144 token context…

We're on a journey to advance and democratize artificial intelligence through open source and open science.

As the volume of data explodes in the clinical, real-world, and commercial realms, AI is becoming the glue that binds disparate information into actionable intelligence. Accordin…

Today, we are releasing our first weights from Trinity-Large, our first frontier-scale model in the Trinity MoE family. American Made. - Trinity-Large-Preview (instruct) - Trinit…

A deep dive into Trinity Large, covering architecture, sparsity, training at scale, and why we shipped Preview, Base, and TrueBase checkpoints.

Introducing Trinity Mini, a compact MoE model trained end-to-end in the U.S., offering open weights, strong reasoning, and full control for developers.

The new machine, the first of its kind in Europe, allows users to visualise what happens when tiny particles hit a surface three times faster than a bullet. This information will…

Railcar products and services provider Trinity Industries (NYSE:TRN) beat analysts

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have a chance to lead - aligning innovation with access dr…